Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature

References

• SchönMPBoehnckeWHPsoriasisN Engl J Med2005352181899191215872205
   PubMed Web of Science ®Google Scholar
• GelfandJMTroxelABLewisJDThe risk of mortality in patients with psoriasis: results from a population-based studyArch Dermatol2007143121493149918086997
   PubMed Web of Science ®Google Scholar
• SternRSNijstenTFeldmanSRMargolisDJRolstadTPsoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfactionJ Investig Dermatol Symp Proc200492136139
   PubMed Web of Science ®Google Scholar
• AugustinMHollandBDartschDLangenbruchARadtkeMAAdherence in the treatment of psoriasis: a systematic reviewDermatology2011222436337421757881
   PubMed Web of Science ®Google Scholar
• KurdSKGelfandJMThe prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004J Am Acad Dermatol200960221822419022533
   PubMed Web of Science ®Google Scholar
• MenterAGottliebAFeldmanSRGuidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologicsJ Am Acad Dermatol200858582685018423260
   PubMed Web of Science ®Google Scholar
• FerrándizCCarrascosaJMToroMPrevalencia de la psoriasis en España en la era de los agentes biológicos. [Prevalence of Psoriasis in Spain in the Age of Biologics]Actas Dermosifiliogr20141055504509 Spanish24569109
   PubMedGoogle Scholar
• LebwohlMGBachelezHBarkerJPatient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis SurveyJ Am Acad Dermatol2014705871881e1e3024576585
   PubMed Web of Science ®Google Scholar
• LangleyRGKruegerGGGriffithsCEPsoriasis: epidemiology, clinical features, and quality of lifeAnn Rheum Dis200564Supp 2ii18ii2315708928
   PubMed Web of Science ®Google Scholar
• BhosleMJKulkarniAFeldmanSRBalkrishnanRQuality of life in patients with psoriasisHealth Qual Life Outcomes200643516756666
   PubMed Web of Science ®Google Scholar
• ChalmersRJAssessing psoriasis severity and outcomes for clinical trials and routine clinical practiceDermatol Clin2015331577125412783
   PubMed Web of Science ®Google Scholar
• RappSRFeldmanSRExumMLFleischerABJrReboussinDMPsoriasis causes as much disability as other major medical diseasesJ Am Acad Dermatol1999413 Pt 140140710459113
   PubMed Web of Science ®Google Scholar
• MrowietzUReichKPsoriasis – new insights into pathogenesis and treatmentDtsch Arztebl Int20091061–21118 quiz 919564982
   PubMed Web of Science ®Google Scholar
• FeldmanSRGartonRAverettWBalkrishnanRValleeJStrategy to manage the treatment of severe psoriasis: considerations of efficacy, safety and costExpert Opin Pharmacother2003491525153312943482
   PubMed Web of Science ®Google Scholar
• MillerDWFeldmanSRCost-effectiveness of moderate-to-severe psoriasis treatmentExpert Opin Pharmacother20067215716716433581
   PubMed Web of Science ®Google Scholar
• BrunassoAMPuntoniMSalviniCTolerability and safety of biological therapies for psoriasis in daily clinical practice: a study of 103 Italian patientsActa Derm Venereol2011911444921088813
   PubMed Web of Science ®Google Scholar
• SaccomaniCPenzSGuerre-SchmidtRUtilisation des biothérapies dans le psoriasis modéré à sévère : expérience du service de dermatologie du CHU de Besançon (2004–2008). [Biological therapy for psoriasis: practical experience at a French dermatology unit]Ann Dermatol Venereol200913612877882 French20004312
   PubMed Web of Science ®Google Scholar
• BerendsMADriessenRJLangewoutersAMBoezemanJBVan De KerkhofPCDe JongEMEtanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practiceJ Dermatolog Treat2007182768317520463
   PubMed Web of Science ®Google Scholar
• de GrootMAppelmanMSpulsPIde RieMABosJDInitial experience with routine administration of etanercept in psoriasisBr J Dermatol2006155480881416965432
   PubMed Web of Science ®Google Scholar
• MazzottaAEspositoMCostanzoAChimentiSEfficacy and safety of etanercept in psoriasis after switching from other treatments: an observational studyAm J Clin Dermatol200910531932419658444
   PubMed Web of Science ®Google Scholar
• AntoniouCStefanakiIStratigosAInfliximab for the treatment of psoriasis in Greece: 4 years of clinical experience at a single centreBr J Dermatol201016251117112319906069
   PubMed Web of Science ®Google Scholar
• WarrenRBBrownBCLaveryDAshcroftDMGriffithsCEBiologic therapies for psoriasis: practical experience in a U.K. tertiary referral centreBr J Dermatol2009160116216918808412
   PubMed Web of Science ®Google Scholar
• CarrollCLFeldmanSRCamachoFTBalkrishnanRBetter medication adherence results in greater improvement in severity of psoriasisBr J Dermatol2004151489589715491434
   PubMed Web of Science ®Google Scholar
• BewleyAPageBMaximizing patient adherence for optimal outcomes in psoriasisJ Eur Acad Dermatol Venereol201125Suppl 491421507078
   PubMed Web of Science ®Google Scholar
• RichardsHLFortuneDGGriffithsCEAdherence to treatment in patients with psoriasisJ Eur Acad Dermatol Venereol200620437037916643132
   PubMed Web of Science ®Google Scholar
• DubertretLMrowietzURankiAEUROPSO Patient Survey GroupEuropean patient perspectives on the impact of psoriasis: the EUROPSO patient membership surveyBr J Dermatol2006155472973616965422
   PubMed Web of Science ®Google Scholar
• KruegerGKooJLebwohlMMenterASternRSRolstadTThe impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership surveyArch Dermatol2001137328028411255325
   PubMed Web of Science ®Google Scholar
• NijstenTMargolisDJFeldmanSRRolstadTSternRSTraditional systemic treatments have not fully met the needs of psoriasis patients: results from a national surveyJ Am Acad Dermatol2005523 Pt 143444415761421
   PubMed Web of Science ®Google Scholar
• LecluseLLTutein NoltheniusJLBosJDSpulsPIPatient preferences and satisfaction with systemic therapies for psoriasis: an area to be exploredBr J Dermatol200916061340134319416228
   PubMed Web of Science ®Google Scholar
• Centre for Evidence-Based Medicine [homepage on the Internet]CEBMOxford, UKCentre for Evidence-Based Medicine2014 Available from: http://www.cebm.net/?o=1025Accessed April 22, 2015
   Google Scholar
• ObradorsMBlanchCComellasMFiguerasMLizanLHealth-related quality of life in patients with psoriasis: a systematic review of the European literatureQual Life Res Epub201663
   Web of Science ®Google Scholar
• ThorneloeRJBundyCGriffithsCEAshcroftDMCordingleyLAdherence to medication in patients with psoriasis: a systematic literature reviewBr J Dermatol20131681203122963128
   PubMed Web of Science ®Google Scholar
• ZschockeIMrowietzUKarakasiliEReichKNon-adherence and measures to improve adherence in the topical treatment of psoriasisJ Eur Acad Dermatol Venereol201428Suppl 24924684738
   PubMed Web of Science ®Google Scholar
• PuigLCarrascosaJMBelinchónIPanel de Expertos del Consenso Delphi sobre Tratamiento tópico de la psoriasisGrupo de Psoriasis de la Academia Española de Dermatología y VenereologíaAdherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the Psoriasis Group of the Spanish Academy of Dermatology and VenereologyActas Dermosifiliogr2013104648849623395400
   PubMedGoogle Scholar
• SchaarschmidtMLKromerCHerrRSchmiederAGoerdtSPeitschWKTreatment satisfaction of patients with psoriasisActa Derm Venereol201595557257825394584
   PubMed Web of Science ®Google Scholar
• van CranenburghODde KorteJSprangersMAde RieMASmetsEMSatisfaction with treatment among patients with psoriasis: a web-based survey studyBr J Dermatol2013169239840523565643
   PubMed Web of Science ®Google Scholar
• Ragnarson TennvallGHjortsbergCBjarnasonATreatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countriesActa Derm Venereol201393444244523138500
   PubMed Web of Science ®Google Scholar
• van den ReekJMvan LüumingPPOteroMESatisfaction of treatment with biologics in high in psoriasis: results from the Bio-CAPTURE networkBr J Dermatol201417051158116524484403
   PubMed Web of Science ®Google Scholar
• SchäferIHackerJRustenbachSJRadtkeMFranzkeNAugustinMConcordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatmentEur J Dermatol2010201626719822480
   PubMed Web of Science ®Google Scholar
• ChristophersESegaertSMilliganGMoltaCTBoggsRClinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational studyJ Dermatolog Treat201324319319822620684
   PubMed Web of Science ®Google Scholar
• RiberaMDaudénEPuigLDesign and validation of a questionnaire to measure treatment satisfaction in patients with moderate-to-severe psoriasis: the NEODERMA study. [Diseño y validación de un cuestionario para medir la satisfacción con el tratamiento del paciente con psoriasis moderada y grave: estudio NEODERMA]Actas Dermosifiliogr201110212838 Spanish21315859
   PubMedGoogle Scholar
• SchaarschmidtMLSchmiederAUmarNPatient preferences for psoriasis treatments: process characteristics can outweigh outcome attributesArch Dermatol2011147111285129422106115
   PubMedGoogle Scholar
• SchaarschmidtMLUmarNSchmiederAPatient preferences for psoriasis treatments: impact of treatment experienceJ Eur Acad Dermatol Venereol201327218719822225546
   PubMed Web of Science ®Google Scholar
• UmarNSchöllgenITerrisDDIt is not always about gains: utilities and disutilities associated with treatment features in patients with moderate-to-severe psoriasisPatient Prefer Adherence2012618719422536054
   PubMed Web of Science ®Google Scholar
• UmarNSchaarschmidtMSchmiederAPeitschWKSchöllgenITerrisDDMatching physicians’ treatment recommendations to patients’ treatment preferences is associated with improvement in treatment satisfactionJ Eur Acad Dermatol Venereol201327676377022631875
   PubMed Web of Science ®Google Scholar
• TorbicaAFattoreGAyalaFEliciting preferences to inform patientcentred policies: the case of psoriasisPharmacoeconomics201432220922324446282
   PubMed Web of Science ®Google Scholar
• Callis DuffinKYeungHTakeshitaJPatient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practiceBr J Dermatol2014170367268024266717
   PubMed Web of Science ®Google Scholar
• FinchTShimTNRobertsLJohnsonOTreatment satisfaction among patients with moderate-to-severe psoriasisJ Clin Aesthet Dermatol201584263026060515
   PubMedGoogle Scholar
• KromerCSchaarschmidtMLSchmiederAHerrRGoerdtSPeitshWKPatient preferences for treatment of psoriasis with biological: a discrete choice experimentPLoS One2015106e012912026058083
   PubMed Web of Science ®Google Scholar
• MrowietzUKragballeKReichKDefinition of treatment goals for moderate to severe psoriasis: a European consensusArch Dermatol Res2011303111020857129
   PubMed Web of Science ®Google Scholar
• TorresTPuigLTreatment goals for psoriasis: should PASI 90 become the standard of care?Actas Dermosifiiogr20151063155157
   PubMed Web of Science ®Google Scholar
• BartonJLPatient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapyPatient Prefer Adherence2009333534420016797
   PubMed Web of Science ®Google Scholar